This study investigates the effects of an investigational medication compared to a daily oral dose of another treatment in adults with relapsing forms of multiple sclerosis (RMS). This study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 who have been diagnosed with RMS.Participants will …
This study investigates the efficacy and safety of an investigational medication in adults with moderate to severe Crohn's Disease (CD). This study compares different doses of the investigational medication with a placebo to determine its effectiveness in managing CD symptoms.Participants will undergo various study procedures, including a Double-Blind (DB) treatment …
This study investigates the efficacy and safety of an investigational medication in adults with moderate-to-severe ulcerative colitis. The study aims to evaluate how different doses of the investigational medication can achieve clinical remission in participants.Participants will undergo various procedures, including a screening period and treatment periods. The study involves a …
This study investigates the safety and efficacy of an investigational antibody in protecting against Respiratory Syncytial Virus (RSV) in young children. This study involves neonates and infants aged 0 to 12 months, as well as children up to 24 months of age who are vulnerable to severe RSV disease.Participants will …
This study investigates the impact of an investigational medication compared to standard care on lung function in adults with uncontrolled moderate to severe asthma. This study aims to determine if the investigational medication can prevent or slow down the decline in lung function.Participants in the study will be randomly assigned …
This study investigates an investigational medication for adults with moderate to severe ulcerative colitis (UC). The purpose of this study is to evaluate the effectiveness and safety of the investigational medication compared to a placebo. Participants will be divided into four study arms, with three different doses of the investigational …
This study investigates the safety and efficacy of an investigational medication for individuals aged 12 and older with moderate to severe atopic dermatitis. The study aims to understand how this medication affects participants over a long-term period.Participants will receive the investigational medication through injections under the skin. This open-label study …
This study investigates the efficacy and safety of an investigational medication in adults with nonrelapsing secondary progressive multiple sclerosis (nrSPMS). The purpose of this study is to determine whether the investigational medication can delay disability progression compared to a placebo.Participants in this randomized, double-blind, placebo-controlled study will receive either the …
This study investigates the long-term safety and tolerability of an investigational medication in adults with multiple sclerosis (MS). Participants in this study have previously been part of earlier trials of the investigational medication.Participants will continue or start open-label treatment with the investigational medication, depending on their previous study involvement. Some …
This study investigates the treatment response and safety of two dose regimens of an investigational medication compared with treatment withdrawal in individuals aged 12 years and older with moderate-to-severe atopic dermatitis. The study aims to see if participants who responded to the investigational medication in earlier studies can maintain their …
